C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2292764
Polymorphisms within a plasma carboxypeptidase designated plasma carboxypeptidase B (PCPB) have been identified. The relative distribution of these polymorphs in a patient's blood can be used to assess an indivudual's risk toward thrombotic disease.
L'invention concerne l'identification de polymorphismes à l'intérieur d'une plasma carboxypeptidase désignée sous le nom de plasma carboxypeptidase B (PCPB). La répartition relative de ces polymorphes dans le sang d'un patient peut permettre d'évaluer le risque d'affections thrombotiques chez un individu.
Morser Michael John
Nagashima Mariko
Marks & Clerk
Schering Aktiengesellschaft
LandOfFree
Method of detecting thrombotic disease risk does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of detecting thrombotic disease risk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting thrombotic disease risk will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1736241